Emergo Therapeutics

About:

Emergo Therapeutics is a pharmaceutical startup that develops treatment options for flu-like illnesses.

Website: http://emergotherapeutics.com/

Top Investors: North Carolina Biotechnology Center, VentureSouth, Rex Health Ventures, Carolina Angel Network, Wolfpack Investor Network

Description:

Emergo Therapeutics is a pharmaceutical startup that develops treatment options for flu-like illnesses. It is focused on developing drugs to modulate inflammatory cytokines and improve the functioning of the immune system in various potential indications, starting with infectious diseases. Emergo’s therapeutic interventions are focused on reducing the production of inflammatory cytokines from mast cells. Emergo is headquartered in Durham, North Carolina.

Total Funding Amount:

$16M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Durham, North Carolina, United States

Founded Date:

2017-01-01

Founders:

Robin Hyde-DeRuyscher

Number of Employees:

11-50

Last Funding Date:

2020-10-12

IPO Status:

Private

Industries:

© 2025 bioDAO.ai